Investment analysts at Deutsche Bank (NYSE: DB) upped their price target on shares of Advisory Board (NASDAQ: ABCO) to $75.00 in a note issued to investors on Thursday.
Separately, analysts at Avondale Partners initiated coverage on shares of Advisory Board in a research note to investors on Wednesday, January 18th. They set an “outperform” rating on the stock.
The Advisory Board Company provides research and analysis, business intelligence and software tools, and installation support and management and advisory services to the health care and education industries. The programs are offered in research, business intelligence and software tools, and installation support and management and advisory services. As of March 31, 2010, the membership consisted of approximately 2,985 members composed of primarily hospitals and health systems, pharmaceutical and biotech companies, as well as health care insurers, medical device and supply companies, and colleges, universities and other educational institutions.
Advisory Board opened at 76.46 on Thursday. Advisory Board has a 52-week low of $45.41 and a 52-week high of $80.70. The stock has a 50-day moving average of $75.09 and a 200-day moving average of $65.57. The company has a market cap of $1.252 billion and a price-to-earnings ratio of 71.39.
Stay on top of analysts' coverage with our daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day. Click here to register.